Biogen, Inc. (BIIB)
172.62
+7.24
(+4.38%)
USD |
NASDAQ |
Jan 21, 16:00
172.78
+0.16
(+0.09%)
Pre-Market: 08:54
Biogen Price: 172.62 for Jan. 21, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1078.52 |
| AbbVie, Inc. | 216.15 |
| Stoke Therapeutics, Inc. | 29.50 |
| Alnylam Pharmaceuticals, Inc. | 365.46 |
| Insmed, Inc. | 156.32 |
Price Related Metrics
| PE Ratio | 15.74 |
| PS Ratio | 2.612 |
| Price to Book Value | 1.391 |
| Price to Free Cash Flow | 11.19 |
| Earnings Yield | 6.35% |
| Market Cap | 25.32B |
| Operating PE Ratio | 10.38 |
| Normalized PE Ratio | 13.96 |